Immunogenicity and Bioassay Summit

At this Immunogenicity & Bioassay Event in the USA, CHI promise to bring together industry, academia and regulatory authorities.

Now in its 11th year, CHI’s Immunogenicity & Bioassay Summit will examine the challenges currently facing the industry and will provide new case studies, new perspectives and new approaches. You can expect to hear from the industry, academia and the regulatory authorities.

This year will feature:

• three conference programs (immunogenicity assessment and clinical relevance; immunogenicity prediction and control; optimizing bioassays for biologics),
• a symposiumn (immunology for biotherapeutics) and
• training seminar (biostatics for beginners).

There will also be many short courses for in-depth study, as well as interactive breakout discussions for sharing of experiences and ideas, and excellent networking opportunities.

For more information and registration visit the Immunogenicity & Bioassay summit website.